CA2294067A1 - Dispositif d'administration d'ingredients dermatologiques - Google Patents

Dispositif d'administration d'ingredients dermatologiques Download PDF

Info

Publication number
CA2294067A1
CA2294067A1 CA002294067A CA2294067A CA2294067A1 CA 2294067 A1 CA2294067 A1 CA 2294067A1 CA 002294067 A CA002294067 A CA 002294067A CA 2294067 A CA2294067 A CA 2294067A CA 2294067 A1 CA2294067 A1 CA 2294067A1
Authority
CA
Canada
Prior art keywords
skin
delivery
dermatological ingredients
dermatological
ingredients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002294067A
Other languages
English (en)
Other versions
CA2294067C (fr
Inventor
Richard L. Devillez
Laura J. Crane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Consumer Care Holdings LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2294067A1 publication Critical patent/CA2294067A1/fr
Application granted granted Critical
Publication of CA2294067C publication Critical patent/CA2294067C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CA002294067A 1997-06-24 1997-06-24 Dispositif d'administration d'ingredients dermatologiques Expired - Lifetime CA2294067C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/011062 WO1998058631A1 (fr) 1997-06-24 1997-06-24 Dispositif d'administration d'ingredients dermatologiques

Publications (2)

Publication Number Publication Date
CA2294067A1 true CA2294067A1 (fr) 1998-12-30
CA2294067C CA2294067C (fr) 2005-11-15

Family

ID=22261154

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002294067A Expired - Lifetime CA2294067C (fr) 1997-06-24 1997-06-24 Dispositif d'administration d'ingredients dermatologiques

Country Status (4)

Country Link
EP (1) EP0991404A1 (fr)
AU (1) AU3791997A (fr)
CA (1) CA2294067C (fr)
WO (1) WO1998058631A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2456025C (fr) * 2001-08-29 2011-11-22 Ricardo A.P. De Carvalho Dispositif scellable et implantable pour l'administration unidirectionnelle d'agents therapeutiques a un tissu
US8870876B2 (en) 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
ES2699257T3 (es) 2013-02-28 2019-02-08 Dermira Inc Sales de glicopirrolato
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US11607026B2 (en) 2014-05-30 2023-03-21 Johnson & Johnson Consumer Inc. Device for delivery of skin care composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4597961A (en) * 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
CA1280111C (fr) * 1985-04-03 1991-02-12 Richard E. Reever. Composition servant a administrer un medicament par voie transdermique
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
CA2115840A1 (fr) * 1991-08-27 1993-03-04 Tsung-Min Hsu Formulation transdermique pour l'administration de prazosine
US5460620A (en) * 1992-07-31 1995-10-24 Creative Products Resource, Inc. Method of applying in-tandem applicator pads for transdermal delivery of a therapeutic agent
WO1996032142A1 (fr) * 1995-04-12 1996-10-17 Hopp Robert B Disque transdermique applicable en immunotherapie de contact

Also Published As

Publication number Publication date
WO1998058631A1 (fr) 1998-12-30
EP0991404A1 (fr) 2000-04-12
AU3791997A (en) 1999-01-04
CA2294067C (fr) 2005-11-15

Similar Documents

Publication Publication Date Title
EP1401421B1 (fr) Methodes et compositions pour le traitement de l'onychomycose et autres pathologies microbiennes et mycosiques
FR2782269B1 (fr) Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation
SE9500422D0 (sv) New oral pharmaceutical dosage forms
AU1793397A (en) Cosmetic or cosmetic preparation for smoothing and tightening the skin in the case of subcutaneous fatty tissue problems, particularly cellulite
MX9706768A (es) Formas de dosificacion efervecente de unidades multiples que contienen inhibidor de la bomba de protones.
PT913156E (pt) Utilizacao de proteina c activada para tratar estados hipercoagulaveis associados com sepsia
YU66600A (sh) Farmaceutski preparati koji mogu da budu gelirani
RU94022017A (ru) Способ лечения акне или псевдофолликулита бороды, способ получения композиции, применение ингибитора фермента орнитиндекарбоксилазы для лечения акне или псевдофолликулита бороды
DE69518334T2 (de) Pharmazeutische aerosol welche mindestens ein zucker enthält
WO1998010767A3 (fr) Utilisation de derives de la quinazoline pour la fabrication d'un medicament destine au traitement de troubles cutanes hyperproliferatifs
CA2025078A1 (fr) Lotion analgesique a usage externe et methode de production
MXPA06005742A (es) Metodo y composicion para el tratamiento de lesiones cutaneas.
EP1806135A3 (fr) Utilisation d'un inhibiteur de la protéine tyrosine tel qu'une génistéine pour le traitement d'une rétinopathie diabétique ou une inflammation oculaire
EP1563844A3 (fr) Composition cicatrisante contenant la fibronectine du plasma humain
PT914110E (pt) Metodo de modulacao da micro-circulacao
ATE249819T1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
NO863935D0 (no) Fremgangsmaate for fremstilling av terapeutiske preparater inneholdende 2-(2-fluor-4-bifenylyl)propionsyre.
NO951498D0 (no) Farmasöytisk preparat for behandling av osteoporose
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
AU2002341366A1 (en) Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucuous membranes
CA2294067A1 (fr) Dispositif d'administration d'ingredients dermatologiques
ES2162051T3 (es) Preparacion dermatologica para tratar queratosis actinicas.
US5268176A (en) Method and compositions for the non-invasive treatment of telangiectasia
GB2210789A (en) Topical application for skin care
ATE227973T1 (de) Kosmetische, dermatologische und pharmazeutische anwendung eines terminalia catappa pflanzenextrakts

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170627